prognosis
Last reviewed 01/2018
The prognosis for a Wilms' tumour patient depends on stage:
- Stage 1 - 80% survival at 5 years
- Stage 3 - 50% survival at 5 years
The prognosis has improved dramatically in recent years such that 66% of those with stage 4 disease and unfavourable histology survive relapse-free for at least 2 years.
Overall survival of patients with bilateral tumours is 64% at 10 years.
Ten percent of tumours have an unfavourable histology, and it is these that account for 50% of the mortality.
Notes:
- Wilms' tumor metastasis occurs in children and adults in 10% and 29% of
the cases, respectively
- nephroblastoma in adults is considered worse than in children
- Stages III and IV are present in 50% of adults and 30% of children
- a higher advancement stage and common metastatic events are the reasons for worse treatment outcomes in adults compared to children
- prognosis depends on the primary advancement stage, the histopathology,
time since the first remission, type of therapy, and the recurrence location
- in patients with recurrence three-year survival is about 30%, especially in the presence of poor prognostic factors such as advanced stage greater than I, abdominal relapse at the site of previous radiotherapy, early recurrence (<12 months)
- nephroblastoma in adults is considered worse than in children
Reference:
- Fawcett, D.. Renal Tumours. Surgery 1994;12(9):193-7.
- Kumar A, Lal B, Singh M, Kapur B. Adult Wilms' tumour: raport of a case and review of the literature. Jpn J Surg. 1990;20:585-589.
- Grundy P, Telzerow P, Moksness J, Moksness J, Breslow N. Clinicopathologic correlates of loss of heterozygosity in Wilms' tumor: a preliminary analysis. Med Pediatr Oncol. 1996;27:429-433